Cognitive-Behavioral Therapy for Pain and Opioid Dependence in Methadone Maintenance Treatment
Study Details
Study Description
Brief Summary
This study involves the comparison of two treatment approaches for patients with chronic pain who are entering methadone maintenance treatment (MMT) for opioid addiction: (a) an integrated counseling that addresses both chronic pain and opioid dependence(POD)and (b) a counseling intervention that addresses opioid dependence only.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Phase 1 |
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Active Comparator: Methadone Drug Counseling Methadone Drug Counseling is provided by skilled drug counselors over a 12 week period and focuses on cessation of illicit drugs |
Behavioral: Methadone Drug Counseling
Methadone Drug Counseling (MDC)is provided by skilled drug counselors over a 12-week period. The primary goal of MDC is cessation of illicit drugs.
|
Experimental: Cognitive-Behavioral Therapy for Pain and Opioid Dependence CBT is provided by skilled psychologists in weekly sessions for 12 weeks and focuses on reducing illicit drug use and increasing pain management. |
Behavioral: Cognitive-Behavioral Therapy for Pain and Opioid Dependence
CBT is provided by skilled psychologists in weekly sessions for 12 weeks and focuses on reducing illicit drug use and increasing pain management.
|
Outcome Measures
Primary Outcome Measures
- Pain reduction [16 weeks]
- Reduce illicit opioid use [16 weeks]
Secondary Outcome Measures
- Finalization of treatment manuals [16 weeks]
- Development and modification of therapy training and process rating measures [16 weeks]
Eligibility Criteria
Criteria
Inclusion Criteria:
-
18 years of age or older
-
prescription opioid or heroin addiction
-
moderate to severe chronic pain
-
enrolled in methadone maintenance at the APT Foundation for opioid addiction
-
understand English
Exclusion Criteria:
-
current suicide or homicide risk
-
life-threatening or unstable medical problem
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Methadone Research Unit | New Haven | Connecticut | United States | 06519 |
Sponsors and Collaborators
- Yale University
- National Institute on Drug Abuse (NIDA)
Investigators
- Principal Investigator: Declan Barry, PhD, Yale University
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 0703002496_B
- K23DA024050-03